These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 12816714)

  • 41. Clinical utility of lens culinaris agglutinin-reactive alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: evaluation in a Thai referral population.
    Tanwandee T; Setthasin S; Charatcharoenwitthaya P; Chainuvati S; Leelakusolvong S; Pausawasdi N; Srikureja W; Pongprasobchai S; Manatsathit S; Kachintorn U; Ekpo P; Senawong S
    J Med Assoc Thai; 2009 Mar; 92 Suppl 2():S49-56. PubMed ID: 19562986
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The first clinical trial for determination of alpha 1 fetoprotein by means of Sevatest-ELISA AFP Kit (micro I).
    Mancal P; Srámek M; Malbohan I; Simek L
    J Hyg Epidemiol Microbiol Immunol; 1988; 32(2):209-17. PubMed ID: 2457612
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Squamous cell carcinoma antigen-immunoglobulin M complexes as novel biomarkers for hepatocellular carcinoma.
    Beneduce L; Castaldi F; Marino M; Quarta S; Ruvoletto M; Benvegnù L; Calabrese F; Gatta A; Pontisso P; Fassina G
    Cancer; 2005 Jun; 103(12):2558-65. PubMed ID: 15887222
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prediction of recurrence of hepatocellular carcinoma after curative ablation using three tumor markers.
    Tateishi R; Shiina S; Yoshida H; Teratani T; Obi S; Yamashiki N; Yoshida H; Akamatsu M; Kawabe T; Omata M
    Hepatology; 2006 Dec; 44(6):1518-27. PubMed ID: 17133456
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An analysis of the UNOS liver transplant registry: high serum alpha-fetoprotein does not justify an increase in MELD points for suspected hepatocellular carcinoma.
    Kemmer N; Neff G; Kaiser T; Zacharias V; Thomas M; Tevar A; Satwah S; Shukla R; Buell J
    Liver Transpl; 2006 Oct; 12(10):1519-22. PubMed ID: 17004260
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Development of an inexpensive and rapid two site microenzyme linked immunosorbent assay kit for human alpha fetoprotein.
    Bansal V; Kumari K; Sahib MK
    Indian J Exp Biol; 1989 Oct; 27(10):907-9. PubMed ID: 2483953
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Clinical application of avidin-biotin ELISA to detect serum hepatoma-specific gamma-glutamyltransferase in patients with primary hepatic cancer].
    Wang NY; Zhao W; Zhang D; Zhang YC; Duan MH
    Zhonghua Zhong Liu Za Zhi; 2009 Feb; 31(2):114-7. PubMed ID: 19538886
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma.
    Soresi M; Magliarisi C; Campagna P; Leto G; Bonfissuto G; Riili A; Carroccio A; Sesti R; Tripi S; Montalto G
    Anticancer Res; 2003; 23(2C):1747-53. PubMed ID: 12820452
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Development of high-performance magnetic chemiluminescence enzyme immunoassay for alpha-fetoprotein (AFP) in human serum.
    Wang X; Zhang QY; Li ZJ; Ying XT; Lin JM
    Clin Chim Acta; 2008 Jul; 393(2):90-4. PubMed ID: 18402780
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Quantitation of alpha-fetoprotein messenger RNA for early detection of recurrent hepatocellular carcinoma: a prospective pilot study.
    Schmilovitz-Weiss H; Stemmer SM; Liberzon E; Avigad S; Sulkes J; Belinki A; Kazatsker A; Ben-Ari Z
    Cancer Detect Prev; 2006; 30(2):204-9. PubMed ID: 16638626
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Biological markers of hepatocellular carcinoma].
    Arfaoui D; Elloumi H; Ajmi S
    Tunis Med; 2004 Apr; 82(4):329-34. PubMed ID: 15453027
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Development of a rapid, immunochromatographic strip test for serum asialo alpha1-acid glycoprotein in patients with hepatic disease.
    Lee EY; Kang JH; Kim KA; Chung TW; Kim HJ; Yoon DY; Lee HG; Kwon DH; Kim JW; Kim CH; Song EY
    J Immunol Methods; 2006 Jan; 308(1-2):116-23. PubMed ID: 16403512
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Serum human telomerase reverse transcriptase messenger RNA as a novel tumor marker for hepatocellular carcinoma.
    Miura N; Maeda Y; Kanbe T; Yazama H; Takeda Y; Sato R; Tsukamoto T; Sato E; Marumoto A; Harada T; Sano A; Kishimoto Y; Hirooka Y; Murawaki Y; Hasegawa J; Shiota G
    Clin Cancer Res; 2005 May; 11(9):3205-9. PubMed ID: 15867214
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Markedly elevated alpha-fetoprotein levels without hepatocellular carcinoma.
    Cheema AW; Hirschtritt T; Van Thiel DH
    Hepatogastroenterology; 2004; 51(60):1676-8. PubMed ID: 15532803
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Does the presence of circulating hepatocellular carcinoma cells indicate a risk of recurrence after resection?
    Jeng KS; Sheen IS; Tsai YC
    Am J Gastroenterol; 2004 Aug; 99(8):1503-9. PubMed ID: 15307868
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The studies on early warning of Lens culinaris-reactive alpha-Fetoprotein (AFP-L3) detecting in primary hepatocellular carcinoma].
    Li YL; Ma HB; Guo JX; Shi JB; Xu J; Liu AX; Yang LH; Li BA; Mao YL
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Oct; 22(5):336-8. PubMed ID: 19469167
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Selective prognostic impact of serum alpha-fetoprotein level in patients with hepatocellular carcinoma: analysis of 543 patients in a single center.
    Huo TI; Huang YH; Lui WY; Wu JC; Lee PC; Chang FY; Lee SD
    Oncol Rep; 2004 Feb; 11(2):543-50. PubMed ID: 14719097
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Combined five tumor markers in detecting primary hepatic carcinoma].
    Ma J; Gong Q; Lin M; Xi Y; Wang M; Chen Z; Pei Z; Ma W
    Zhonghua Wai Ke Za Zhi; 2000 Jan; 38(1):14-6. PubMed ID: 11831976
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Serum golgi phosphoprotein 2 level: a better marker than alpha-fetoprotein for diagnosing early hepatocellular carcinoma.
    Li X; Wu K; Fan D
    Hepatology; 2009 Nov; 50(5):1682. PubMed ID: 19739256
    [No Abstract]   [Full Text] [Related]  

  • 60. Serum markers of hepatocellular carcinoma.
    Spangenberg HC; Thimme R; Blum HE
    Semin Liver Dis; 2006 Nov; 26(4):385-90. PubMed ID: 17051452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.